P/B
4,2
Pro-Dex
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
$199.3M
Market Cap • 10/8/2026
1994
(32 years)
Founded
1986
(40 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,6
P/EBITDA
13,9
P/OCF
27,5
P/FCF
29,5
P/E
15,1
BVPS
14,9
EPS
4,1
Market Cap
Market Cap
199,3M
EV
208M
EV/Revenue
2,7
EV/EBITDA
14,5
EV/EBIT
16
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
1,7%
Total Yield
1,7%
Payout
0%
Retained Earnings
47,6M
Profitability
Gross Margin
31,4%
EBITDA Margin
18,5%
EBIT Margin
16,8%
Net Margin
28,8%
D&A/EBITDA
0%
R&D/Revenue
4,3%
Capex/Revenue
0,6%
Capex/D&A
34,6%
Capex/OCF
6,7%
SBC/OCF
9,5%
% PPE
16%
% Goodwill
8,8%
ROE
53,1%
ROIC
25,5%
Growth
CAGR Revenue 5Y
15,3%
CAGR Op. Income 5Y
23,5%
CAGR Net Income 5Y
29,4%
CAGR EPS 5Y
22,7%
Leverage
N.D./EBITDA
0,6
Debt/Equity
0%
Current Ratio
4,1
Quick Ratio
2,4
Interest Coverage
1599,9%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!